Agenus Inc. News
The Case For a Biotech Snapback
After a challenging year, shares of biotech companies could see rebound following tax loss selling, Bret Jensen says.
Jensen: How to Play Agenus Using Options
Real Money's Bret Jensen outlines simple strategy to use with cancer drug maker.
Bristol-Myers Higher on Progress With Lymphoma-Drug Trial
Bristol-Myers Squibb shares climb after the drugmaker reports progress with a Phase 3 study of a lymphoma treatment.
Buy-the-Dip Candidates: Cramer Likes Abbott Labs, Danaher, and Thermo Fisher
These stocks that fell in the past week could be buy-the-dip opportunities. Recent losers include Okta, Match Group, Procter & Gamble, and more.
Agenus Shares Blast Higher on Deal with Bristol Myers
Bristol Myers Squibb agrees to pay Agenus up to $1.56 billion for the rights to its experimental immuno-cancer treatment.
Elon Musk Says Only Two Things Could Make Him Leave Tesla
Tesla CEO Musk discusses succession plans and Twitter with shareholders.
Caesars Inches Closer to Huge Las Vegas Strip Move
The company has made clear what it plans on the Las Vegas Strip, but it has a fast-approaching deadline.
Elon Musk Has Bad News About Tesla's Cybertruck
Long-delayed futuristic looking electric vehicle will be in production by the middle of 2023